当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 利润表

华兰生物

(002007)

  

流通市值:644.50亿  总市值:750.36亿
流通股本:15.67亿   总股本:18.24亿

利润表

按照会计年度查询:
报告期2020-03-312019-12-312019-09-302019-06-30
一、营业总收入677,541,355.353,699,941,990.22,638,440,901.591,402,608,966.25
营业收入677,541,355.353,699,941,990.22,638,440,901.591,402,608,966.25
二、营业总成本388,639,962.082,213,555,523.731,536,440,474.31849,451,691.09
营业成本261,141,945.521,296,699,766.29965,513,517.05571,631,828.75
营业税金及附加5,817,989.1731,517,837.1421,958,187.8513,344,416.8
销售费用35,239,741520,429,807.19293,494,455.22100,524,558.19
管理费用54,521,072.3217,579,866.05154,468,647.9497,992,123.44
财务费用-1,011,219.883,788,591.56-4,071,967.77-2,241,412.95
资产减值损失---49,466,007.03-12,584,300.96-1,083,371.87
三、其他经营收益--------
允许价值变动净收益-12,883,592.3232,398,952.37----
投资净收益14,633,617.69138,636,408.41101,829,948.4440,420,942.7
联营、合营企业投资收益-1,807,024.0413,675,015.6718,799,920.44-10,848,111.28
汇兑净收益--------
四、营业利润294,018,103.151,615,198,890.761,210,927,561.37609,535,288.75
营业外收入308,945.232,323,024.422,171,616.181,774,707.12
营业外支出2,308,767.47,285,084.395,098,145.273,636,991.14
非流动资产处置净损失--------
五、利润总额292,018,280.981,610,236,830.791,208,001,032.28607,673,004.73
所得税54,589,241.18231,360,092.92192,114,131.14109,544,254.8
未确认的投资损失--------
六、净利润(百万元)1,283.45963.81506.98259.51
少数股东损益-9,857,386.795,427,687.8952,071,933.32-8,848,265.15
归属于母公司股东的净利润247,286,426.51,283,449,049.98963,814,967.82506,977,015.08
七、每股收益--0.910.690.36
基本每股收益0.180.910.690.36
稀释每股收益0.180.910.690.36
TOP↑